Semnur Pharmaceuticals, Inc.
SMNR
$8.00
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -96.41% | 30,373.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -95.96% | 15,174.67% | |||
| Operating Income | 95.96% | -15,174.67% | |||
| Income Before Tax | 95.96% | -15,174.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 95.96% | -15,174.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 95.96% | -15,174.67% | |||
| EBIT | 95.96% | -15,174.67% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 96.26% | -12,103.23% | |||
| Normalized Basic EPS | 96.26% | -12,025.64% | |||
| EPS Diluted | 96.26% | -12,103.23% | |||
| Normalized Diluted EPS | 96.26% | -12,025.64% | |||
| Average Basic Shares Outstanding | 7.81% | 26.05% | |||
| Average Diluted Shares Outstanding | 7.81% | 26.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||